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irst-Pass and Steady-State MR Angiography of
horacic Vasculature in Children and Adolescents
laas P. Naehle, MD,* Michael Kaestner, MD,† Andreas Müller, MD,*
infried W. Willinek, MD,* Juergen Gieseke, PHD,‡ Hans H. Schild, MD,*
aniel Thomas, MD*
onn, Sankt Augustin, and Hamburg, Germany
agnetic resonance angiography (MRA) is an establishednoninvasive imagingmodality for detection and
valuation of vascular pathologies in children with congenital heart disease. Standard first-pass (FP)–MRA
ses a 3-dimensional MRA sequence with an extracellular contrast agent, in which spatial resolution is
imited by breath-hold duration, and image quality (IQ) is limited by motion artifacts. The purpose of this
tudy was to compare the diagnostic confidence, IQ, and image artifacts of standard FP-MRA to a high-
esolution, motion compensated steady-state (SS)–MRA of the thoracic vasculature in children and ado-
escents with congenital heart disease using a blood-pool contrast agent (gadofosveset trisodium). SS-
RA of the thoracic vasculature (technically successful in 90% of patients) offers superior diagnostic
onfidence and IQ compared with FP-MRA and shows fewer motion-related image artifacts. In addition,
S-MRA revealed findings missed by FP-MRA. Therefore, SS-MRA may prove specifically beneficial for
maging of thoracic vessels that are small and/or subject to motion. (J Am Coll Cardiol Img 2010;3:
04–13) © 2010 by the American College of Cardiology Foundationt
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Augagnetic resonance angiography (MRA) has
een established as a noninvasive alternative to
onventional angiography for detection and
valuation of vascular pathologies in children
See page 514
nd adolescents with congenital and acquired
eart disease (1,2). The main advantages of
RA over conventional radiographic an-
iography and echocardiography for visual-
zation of the thoracic vasculature are lack of
adiation, noninvasiveness, a relatively large
eld of view, and independence of an acous-
rom the *Department of Radiology, University of Bonn, Bonn,
ongenital Heart Disease, Deutsches Kinderherzzentrum, Sankt
amburg, Germany.anuscript received August 5, 2009; revised manuscript received Noveic window (1,2). To date, standard MRA for
ssessment of arterial and venous anomalies
n children and adolescents is performed
sing a 3-dimensional (3D) single- or mul-
iphase first-pass (FP)–MRA sequence with
n extracellular contrast agent without car-
iac gating during 1 (or more) breath-
old(s). Using this approach, spatial resolu-
ion is limited by the maximum breath-hold
uration. In addition, standard contrast-
nhanced 3D MRA is usually neither elec-
rocardiogram (ECG)-gated nor does it use
espiratory motion compensation, and thus it
s prone to motion artifacts.
many; †Department of Pediatric Cardiology and
ustin, Germany; and ‡Philips Medical Systems,mber 18, 2009, accepted December 14, 2009.
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505Recently, gadofosveset trisodium (Vasovist,
chering AG, Berlin, Germany [at this time named
S-325]), a blood-pool contrast agent, has been
ntroduced, allowing for prolonged imaging up to
0 min after administration with potential improve-
ent of spatial resolution compared with FP-MRA
3). Even though the superiority of high-resolution
teady-state (SS)–MRA over standard-resolution
P-MRA has been reported in peripheral MRA,
he value of gadofosveset trisodium for MRA of the
horacic vasculature has not been evaluated yet.
Thus, the aim of this study was to evaluate an
CG-gated, high-resolution, free-breathing SS-
RA sequence and compare it to a standard
P-MRA using a blood-pool contrast agent in
hildren and adolescents with congenital heart
isease and acquired disease of the thoracic vas-
ulature.
aterials andMethods
tudy Population
e retrospectively identified 57 patients with con-
enital heart disease or acquired disease of the
horacic vasculature who underwent MRA of the
horacic vasculature between August 2008 and Jan-
ary 2009. Among these were 22 patients (8 to 18
ears) in whom an MRA was performed after
ntravenous injection of gadofosveset trisodium.
he institutional review board of the relevant insti-
ution approved the study protocol.
agnetic Resonance (MR) Imaging
ontrast-enhanced MRA was performed after in-
ection of gadofosveset trisodium using a commer-
ial power injector (Spectris, Medrad, Volkach,
ermany). The contrast agent was injected at a
ose of 0.03 mmol/kg bodyweight and at a rate of
to 1.5 ml/s (depending on patient size), followed
y a 20-ml saline flush at 1.5 ml/s.
All studies were performed on a clinical whole-
ody 1.5-T scanner (Achieva, Philips Medical Sys-
ems, Best, the Netherlands) equipped with 30-
T/m maximum field gradients and a 150-T/m/s
lew rate, using a cardiac phased-array coil. After
cquisition of scout images, functional steady-state
ree-precession cine images were acquired, covering
he heart in the short axis, horizontal and vertical
ong axes, and the left ventricular outflow tract and,
here appropriate, the right ventricular outflow
ract. Flow measurements were performed in the
scending aorta and pulmonary trunk. MRA was rerformed at the end of the entire scanning proce-
ure, where the FP-MRA was followed by the
S-MRA. For the multiphase FP-MRA, a stan-
ard T1-weighted 3D gradient-echo-sequence with
centric ordered k-space acquisition scheme was
sed. Using this approach, the scan duration for 1
ynamic scan is approximately 12 to 18 s. A total of
dynamics was acquired during 2 breath-holds. For
he SS-MRA, a T1-weighted 3D inversion recovery
equence with ECG-triggering and navigator-
ased respiratory motion compensation was used.
S-MRA was acquired 2 to 3 min after FP-MRA.
similar pulse sequence has previously been de-
cribed for contrast-enhanced imaging of the coro-
ary arteries and shown to deliver excellent
ontrast-to-noise ratio for vascular structures (4).
he inversion time was set to create the highest
ontrast between the thoracic vessels and the sur-
ounding tissue, and was chosen using the Look-
ocker approach. Detailed sequence parameters are
iven in Table 1.
mage analysis. Analysis of MR images
ith regard to image quality, image arti-
acts, and diagnostic content was per-
ormed using a commercially available,
endor-specific computer and software
latform (View Forum 5.22, Philips, Best,
he Netherlands).
ISUAL ASSESSMENT OF CARDIAC MAG-
ETIC RESONANCE (CMR) IMAGES. Both
ypes of MRA sequences were analyzed
eparately by 2 experienced readers who
ere blinded to the results of the other reader as
ell as clinical data. For image analysis, the review-
rs had access to both maximum intensity projec-
ions as well as the source data.
Image quality. Image quality was rated using
aximum intensity projections of both types of
RA sequences using a 5-point grading scale.
re-defined vessels (main pulmonary artery, proxi-
al pulmonary arteries, lobar pulmonary artery
ranches, second-generation pulmonary artery
ranches, pulmonary veins, superior vena cava, aor-
ic bulbus, ascending aorta, aortic arch including
ortic isthmus, thoracic descending aorta, coronary
stia, coronary sinus) were graded separately for
mage quality with respect to border definition
blurring of vessel contours): 1  excellent image
uality (good delineation of the vessel border), 2 
ood image quality (very little blurring of the vessel
order), 3  fair image quality (some vessel blur-
A B B
A N D
3D
CMR
reson
ECG
FP
MRA
angio
SS sing), 4 poor image quality (severe blurringR E V I A T I O N S
A C R O N YM S
3-dimensional
cardiac magnetic
ance
electrocardiogram
first-pass
magnetic resonance
graphyof the
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506essel border), 5  nondiagnostic image quality
vessel border unidentifiable).
Image artifacts. The CMR images were graded
or presence of overall artifacts and their interfer-
nce with diagnostic content using a 4-point grad-
ng scale: 1 no artifacts present, 2mild artifacts
ithout interference with diagnostic content,
 moderate artifacts degrading diagnostic content,
 severe artifacts resulting in nondiagnostic images.
Confidence of diagnosis. The CMR images were
nally graded for overall diagnostic confidence di-
gnosis using a 3-point grading scale: 1  high
ertainty of diagnosis, 2  sufficient confidence of
iagnosis, 3  low certainty of diagnosis.
ESSEL SHARPNESS. To determine vessel sharp-
ess, an intensity profile along a user-specified
egment along representative vessels (ascending
orta, left pulmonary artery left, upper pulmonary
ein) was created with a public domain image
rocessing software (ImageJ, U.S. National Insti-
utes of Health, Bethesda, Maryland). To ensure
ata consistency, all vessel sharpness measurements
ere performed by Reviewer #1. The distance
etween 20% and 80% of maximum intensity was
easured for each side of the profile and then
veraged. The reciprocal of the averaged distance
as taken as sharpness. Using this approach, a
reater value for vessel sharpness was consistent
ith a better vessel definition.
DDITIONAL CLINICAL INFORMATION. Both types
Table 1. Detailed Sequence Parameters of FP- and SS-MRA
Parameter FP-MRA
Repetition time/time-to-echo 2.6/1 ms
Inversion time NA
Angle of excitation 25°
Acquisition window NA
Number of slices 75–100
Matrix 352  317 (reconstructed 51
Field of view 450 mm
Slice thickness 1.5 mm
Voxel size 1.3  1.4  1.5 mm
Number of signal averages 2
k-space acquisition CENTRA
Parallel imaging SENSE (factor 4)
Motion suppression technique none
CENTRA contrast-enhanced robust-timing angiography; ECG electrocardiog
NSA  number of signal averages; SENSE  sensitivity encoding; SS  steady-f MRA sequences were analyzed for additional (linical information. Additional clinical informa-
ion was defined as any finding that could exclu-
ively be obtained from either type of MRA
equence. In addition, it was verified that this
nformation could not be obtained from any other
ype of CMR sequence (such as scout images,
ine images, etc.) performed in the specific
atient.
TATISTICAL ANALYSIS. Data analysis was per-
ormed by using commercially available software
Analyse-it for Microsoft Excel version 2.12,
nalyse-it Software, London, United Kingdom).
ll data are given as mean  SD. Qualitative
cores for image quality and quantitative mea-
urements of vessel diameters and vessel sharp-
ess were compared using the Wilcoxon signed-
ank test as a normal distribution could not be
ssumed. Spearman correlation between both re-
iewers was calculated for inter-rater agreement
n image quality grading. The level of signifi-
ance was set to 0.05 for all tests.
esults
f the 22 patients identified following the inclu-
ion criteria, 2 (9.1%) had to be excluded from
urther analysis, because poor performance of the
espiratory navigator did not allow them to com-
lete the SS-MRA scan. The remaining 20
atients constituted the final study population
SS-MRA
4/1.4
Determined by Look-Locker sequence (range
195–310 ms)
25°
120–150 ms, depending on patient=s heart rate
100
512) 368  368 (reconstructed 512  512)
360 mm
1 mm
0.98  0.98  1 mm
Children: 1 NSA w/o fold-over suppression
Juveniles: 2 NSA with fold-over suppression
Low-high
Children: SENSE (factor 2 w/o fold-over suppression
Juveniles: SENSE (factor 4 with fold-over
suppression)
Navigator motion compensation, ECG-gating
FP ﬁrst-pass; MRAmagnetic resonance angiography; NA not applicable;
; w/o  without.2 
ram;mean age: 12.4 years, range 8 to 18 years; 15
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507en, 5 women). For further patient characteris-
ics, see Table 2. In 1 of 20 patients (5%), the
S-MRA had to be repeated, because in the
nitial SS-MRA, an inappropriate inversion time
as chosen. The mean inversion time leading to
ppropriate nulling of the surrounding soft tissue
as 231  24 ms (range 195 ms to 310 ms).
maging duration for the SS-MRA was 5:53 
:30 min (range 4:59 to 7:02 min).
mage quality. For all vessels evaluated (except the
obar pulmonary artery branches graded by Re-
iewer #1 [p  0.1465]), the SS-MRA showed
ignificantly higher image quality grading (p 
.05) for both reviewers (Table 3). This improve-
ent in image quality was most apparent for the
ain pulmonary artery (mean improvement: 1.05
.82), the pulmonary veins (mean improvement:
.18  0.71), the aortic bulbus (mean improve-
ent: 1.53  0.75), the coronary ostia (mean
mprovement: 1.98  1.01), and the coronary sinus
mean improvement: 1.43  0.88), where the mean
mprovement in image quality translates into an
mprovement on the grading scale 1 step. Inter-
Table 2. Patients’ Characteristics: Age, Sex, Primary Cardiac Dia
SS-MRA Versus FP-MRA
Patient # Age (years) Sex Primary Cardiac Diagnosis
1 16 M ISTA
2 16 W Pulmonary valve stenosis
3 14 M L-TGA
4 14 M ASD
5 12 M D-TGA
6 12 M TAC
7 10 M ASD
8 10 M TGA
9 10 M TGA
10 14 M DORV
11 10 M Pulmonary vein stenosis
12 8 W SVD
13 8 W TOF
14 10 W TOF and DORV
15 10 M TOF
16 14 M ISTA
17 14 W ISTA
18 15 M SVD
19 8 M TGA
20 18 M TGA
*Additional ﬁndings in SS-MRA compared with FP-MRA.
ASD  atrial septal defect; CMR  cardiac magnetic resonance; D  dextro; DO
sinus venosus defect; TAC  common arterial trunk (truncus arteriosus comm
abbreviations as in Table 1.bserver agreement was higher for the SS-MRA
han the FP-MRA for all vessels except the lobar
ulmonary artery branches (Table 3).
verall image artifacts. Both reviewers judged that
he FP-MRA showed significantly more overall
mage artifacts than the SS-MRA did (Reviewer
1—FP-MRA: 2.75  0.43 vs. SS-MRA: 1.80 
.75, p  0.0001; Reviewer #2—FP-MRA: 2.70 
.46 vs. SS-MRA: 1.75  0.70, p  0.0001). The
ean reduction in overall image artifacts of 0.95 
.69 translates into a 1-step improvement in the
-point grading scale.
iagnostic conﬁdence. The SS-MRA yielded a sig-
ificantly (p  0.0001) higher overall diagnostic
onfidence for both reviewers (Reviewer #1—FP-
RA: 2.00  0.45 vs. SS-MRA: 1.30  0.46, p 
.0001; Reviewer #2—FP-MRA: 2.00  0.45 vs.
S-MRA: 1.30  0.46, p  0.0001). The mean
ifference in diagnostic confidence between the
S-MRA and the FP-MRA was 0.68  0.54.
essel sharpness. Compared to the FP-MRA, the
S-MRA yielded a significantly (p  0.0001)
igher vessel sharpness for the ascending aorta
sis, Indication for CMR and Additional Clinical Information in
Indication for CMR
Additional Clinical
Information*
Follow-up after repair None
Follow-up after repair None
Follow-up after repair None
Pre-operative assessment Partial anomalous venous return
Follow-up after repair None
Follow-up after repair and
pre-operative assessment
Coronary ostia
Pre-operative assessment None
Follow-up after repair None
Follow-up after repair None
Follow-up repair None
Follow-up after repair None
Pre-operative assessment None
Follow-up after repair None
Follow-up repair None
Follow-up after repair None
Follow-up after repair None
Follow-up after repair None
Follow-up after repair Partial anomalous venous return
Follow-up after repair None
Follow-up after repair and
pre-operative assessment
Coronary sinus
double outlet right ventricle; ISTA  aortic isthmus stenosis; L  levo; SVD 
); TGA  transposition of the great arteries; TOF  tetralogy of Fallot; othergno
RV 
unis
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508FP-MRA: 0.38 0.09 vs. SS-MRA: 0.53 0.13,
 0.0001), the left pulmonary artery (FP-MRA:
.33  0.05 vs. SS-MRA: 0.63  0.11, p 
.0001), and the left upper pulmonary vein (FP-
RA: 0.36  0.09 vs. SS-MRA: 0.58  0.11, p 
.0001).
dditional clinical information. In 4 of 20 (20%)
MR examinations, the SS-MRA showed addi-
ional clinical information, which could be exclu-
ively identified in the SS-MRA, and could not be
epicted in the FP-MRA (Table 2). In none of the
patients (0%) could the additional clinical infor-
ation be depicted in any other CMR sequence
erformed. These findings included a partial anom-
lous venous return in 2 patients and in 1 patient
he coronary sinus and the coronary ostia, respec-
ively. No additional clinical information was found
or the FP-MRA versus the SS-MRA.
iscussion
ongenital anomalies of the thoracic vascular sys-
em are an important cause of morbidity and
ortality in infants and children (5), and although
he perioperative and long-term morbidity and
ortality have decreased, correct diagnosis is crucial
or planning of surgery and the life long follow-up
f these patients (1,5). In the past decade, MRA
as become an important imaging modality for
valuation of pathologies of the thoracic vascula-
ure. Especially in children and adolescents, the lack
f radiation and the noninvasiveness is a major
dvantage of CMR angiography over catheteriza-
ion and computed tomography in this patient
opulation.
echnical/sequence considerations. To date, stan-
ard MRA of the thoracic vessels is performed
sing contrast-enhanced FP 3D gradient-echo-
equences with extracellular contrast agents. Be-
ause of the properties of the extracellular contrast
gents, imaging is restricted to the first pass, max-
mum second pass, of the contrast agent. Thus, data
cquisition is limited to the breath-hold duration,
hich consequently limits the spatial resolution
chievable. In addition, using standard, commer-
ially available software packages, respiratory com-
ensation techniques, and ECG-gating cannot be
ombined with FP-MRA. However, especially in
hildren, the quality of the acquired image data is
ften compromised by respiratory motion artifacts
ue to the inability to follow verbal commands.Consequently, image quality and diagnostic confi-
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509ence are often limited in FP-MRA of children and
dolescents. Here, the use of a blood-pool agent has
everal advantages. Imaging time is not restricted to
he first pass, but can be performed during the
lood-pool–phase of up to 60 min after contrast
gent injection (3). Therefore, motion artifacts can
e reduced by combining navigator-respiratory
ompensation and ECG-gating, and the maximum
patial resolution achievable is no longer limited by
he first pass of the contrast agent. It should be
oted that navigator-based respiratory motion com-
ensation is dependent on a good performance of
he respiratory navigator. In our study, it was
ometimes challenging to obtain a reliable navigator
ignal, especially in smaller children with only small
iver-lung-interface and little respiratory excursion
f the diaphragm. However, this was only the case
n 2 of 22 (9.1%) patients.
In this study, the high-resolution SS-MRA
howed higher image quality for all vessels rated
nd showed less overall image artifacts, resulting in
higher diagnostic confidence than FP-MRA. This
ay, in part, be ascribed to the fact that the high-
esolution approach yielded significantly better ves-
el sharpness, thus improving vessel definition.
essel sharpness itself was not only improved due to
he higher spatial resolution, but also due to motion
ompensation through navigator-respiratory com-
ensation in comparison to the breath-hold, non-
ated FP-MRA, and through ECG-gating. The
cquisition window was specifically chosen to allow
or motion artifact–free imaging of the pulmonary
rtery and pulmonary veins. A shorter acquisition
indow would have been desirable to improve
ssessment of the coronary ostia and proximal
oronary arteries, but it was felt that an acquisition
indow of 120 to 150 ms was the best compromise
etween temporal resolution and scan duration. To
inimize vessel blurring, especially of the pulmo-
ary vessels, and thus to increase vessel sharpness,
mage acquisition was limited to end-expiration,
nd an appropriate length of the acquisition win-
ow was chosen to fit data acquisition into mid-
iastole. This optimization of sequence parameters
f the SS-MRA increased image quality especially
n those vessels, which are mainly subjected to
ardiac and respiratory motion (e.g., aortic bulbus,
oronary ostia and sinus, pulmonary veins).
Although the SS-MRA offers all the advantages
f a near isotropic 3D sequence, such as the
ossibility of multiplanar reformatting in any de-
ired plane (Fig. 1), no information on flow dynam-
cs can be obtained from the SS-MRA (Fig. 2).owever, because dynamic information is impor-
ant for assessment of intra- or extracardiac shunts
n congenital heart disease as well as for the assess-
ent of lung perfusion, the intention of this study
s not to advocate the use of a single high-resolution
equence, but instead to demonstrate the added
alue of a combined imaging approach. Using the
pproach with a single injection of gadofosveset
risodium, both the dynamic information from the
P-MRA and the superior image quality of the
S-MRA can be used for image reading and inter-
retation. Whereas some authors have emphasized
he value of ultrafast time-resolved dynamic MRA
contrast-enhanced robust-timing angiography–
eyhole, time-resolved echo-shared angiographic
echnique, time-resolved imaging of contrast kinet-
cs) for visualization of pulmonary vessels, because
rteriovenous overlay is reduced (1), arteriovenous
verlay was not felt to be an issue for vessel measure-
ents in this study. The use of ultrafast time-resolved
ynamic MRA and high-resolution SS-MRA war-
ants further investigation. However, at the time of
Figure 1. Fourteen-Year-Old Patient With Congenital Aortic Isth
Percutaneous transluminal angioplasty with dilation had been perfo
and 8 years. The patient was now referred for evaluation of suspect
aortic isthmus (arrows). (A) Multiplanar reformatted image maximum
showing the ﬁrst-pass magnetic resonance angiography (MRA). Mea
dence of Reviewers #1 and #2 was 2, and mean rating for overall ar
#1 and #2 was 3. (B) Multiplanar reformatted image maximum inten
ing the steady-state MRA with a higher image quality than the ﬁrst-
diagnostic conﬁdence of Reviewers #1 and #2 was 1, and mean ratimus Stenosis
rmed at the age of 2
ed re-stenosis of the
intensity projection
n diagnostic conﬁ-
tifacts of Reviewers
sity projection show-
pass MRA. Mean
ng for overall arti-facts of Reviewers #1 and #2 was 2.
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510his study, the required software package was not
vailable on the CMR system used for this study.
A potential drawback of the high-resolution
S-MRA sequence is the susceptibility to arrhyth-
ias. Also, image acquisition can become very long
10 min) in patients with a very irregular breath-
ng pattern, even when a motion-adaptive gating
lgorithm is used with navigator-respiratory gating.
n fact, in our patient group poor navigator perfor-
ance did not allow patients to finish the SS-MRA
n 2 cases. However, in patients who are unable to
ollow verbal commands or to hold their breath
Fig. 2), the ability to use navigator-respiratory
ating becomes clinically beneficial.
linical considerations. DIAGNOSTIC CONFIDENCE.
urrently, thoracic MRA in children and adoles-
Figure 2. Fifteen-Year-Old Patient After Repair of Sinus Venosu
Was Not Corrected
The patient was referred for visualization of the anomalous venous
matted maximum intensity projection images on the left side (A, C
partial anomalous venous return (arrows) was not possible due to
of Reviewers #1 and #2 was 2, and mean rating for overall artifacts
reformatted maximum intensity projection images (B, C, E, H) allow
For the steady-state MRA, mean diagnostic conﬁdence of Reviewers
#1 and #2 was 2. Abbreviation as in Figure 1.ents is most frequently used for diagnosis and eollow-up of congenital heart disease. The accurate
elineation of fast-moving vascular structures such
s the coronary ostia, major aortopulmonary collat-
rals, or partial anomalous venous return poses a
hallenge for standard FP-MRA. In the present
tudy, both reviewers rated the coronary sinus as
ondiagnostic in 6 cases for the FP-MRA versus no
ase for the SS-MRA, and the coronary ostia as
ondiagnostic in 18 cases (FP-MRA) versus 1 case
SS-MRA). In respect thereof, this noticeable im-
rovement of image quality of the SS-MRA over
he FP-MRA may constitute a clinically relevant
dvantage.
DDITIONAL CLINICAL INFORMATION. Multiple
maging modalities, such as chest radiography,
fect, During Which a Partial Anomalous Venous Return
rn and for quantiﬁcation of the resulting shunt. Multiplanar refor-
G) showing the ﬁrst-pass MRA, in which the identiﬁcation of the
ion artifacts. For the ﬁrst-pass MRA, mean diagnostic conﬁdence
eviewers #1 and #2 was 3. Only the steady-state MRA multiplanar
for identiﬁcation of the partial anomalous venous return (arrows).
and #2 was 1, and mean rating for overall artifacts of Reviewerss De
retu
, E,
mot
of R
ed
#1chocardiography, conventional angiography,
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511omputed tomography, and MR are typically
sed to diagnose vascular anomalies and for
lanning of subsequent treatment. In compari-
on, CMR has been shown to demonstrate the
bnormalities of pulmonary veins more accurately
han cardiac angiography and echocardiography
s it provides rapid and comprehensive 3D ana-
omic definition of the pulmonary veins (2). In up
o 29% of patients, MRA has been demonstrated
o clarify uncertain echocardiography findings;
elative to X-ray angiography, 3D contrast-
nhanced MRA was found to provide clinically
ew and important information in 46% of the
atients (5). In this context, the superiority of 3D
P-MRA over conventional imaging techniques
ay even be exceeded by the SS-MRA, which
howed additional clinically relevant findings in 4
atients (4 of 20, 20%) that could solely be seen
n the SS-MRA and could not be detected in the
Figure 3. Eighteen-Year-Old Patient With Total Situs Inversus
for Identiﬁcation of a Transvenous Access to the Coronary Si
System
Multiplanar reformatted maximum intensity projection images (A a
the coronary sinus (arrows) itself and the identiﬁcation of a transve
nar reformatted maximum intensity projection images (B and D) al
transvenous access to the coronary sinus, which only then could al
pass MRA, mean diagnostic conﬁdence of Reviewers #1 and #2 was
For the steady-state MRA, mean diagnostic conﬁdence of Reviewers
#1 and #2 was 2. Abbreviation as in Figure 1.P-MRA (Table 2). It should be noted that in
hese 4 patients, the SS-MRA was rated an image
uality that was in average 1.25 higher (range 0.5
o 2.5) than for the FP-MRA, indicating that the
S-MRA may prove especially helpful in case of
n impaired image quality in the FP-MRA and
erve as a clinically helpful add-on sequence. Two
f these patients are especially noteworthy, as the
lanning of an invasive/surgical procedure pri-
arily relied on CMR: 1) An 18-year-old patient
ith total situs inversus and repair of transposi-
ion of the great arteries was referred to identify
possible venous access to the coronary sinus
efore a planned implantation of a biventricular
acemaker system. In this patient, only the SS-
RA allowed for reliable identification of a
ossible transvenous access to coronary sinus for
mplantation of a right/left ventricular pacing
ead (Fig. 3). This finding was later confirmed by
Repair of Transposition of the Great Arteries Referred
Before Planned Implantation of a Biventricular Pacemaker
) showing the ﬁrst-pass MRA, in which reliable identiﬁcation of
s access were not possible. Only the steady-state MRA (multipla-
d for reliable identiﬁcation of the coronary sinus (arrows) and a
e identiﬁed retrospectively on the ﬁrst-pass MRA. For the ﬁrst-
nd mean rating for overall artifacts of Reviewers #1 and #2 was 3.
and #2 was 2, and mean rating for overall artifacts of Reviewersand
nus
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512ardiac catheterization. 2) A 12-year-old patient
ith repair of a common trunk was primarily
eferred to our department for quantification of a
rogressive insufficiency of the aortic valve. In
his patient, the initial diagnosis of a quadricus-
id aortic valve was made, necessitating recurrent
urgery for valve repair/replacement. For plan-
ing of the procedure, the exact locations of the
oronary ostia were important for the cardiac
re 4. Twelve-Year-Old Patient With Repair of a Common Trunk
valuation of Progressing Aortic Valve Insufﬁciency
es show multiplanar reformatted maximum intensity projections
e ﬁrst-pass MRA (A) and the steady-state MRA (B). Only the
y-state MRA allowed for identiﬁcation of the location of the coro-
ostia (arrows), which was important for recurrent surgery with
cement of the aortic valve. For the ﬁrst-pass MRA, mean diagnos-
onﬁdence of Reviewers #1 and #2 was 2, and mean rating for
all artifacts of Reviewers #1 and #2 was 3. For the steady-state
, mean diagnostic conﬁdence of Reviewers #1 and #2 was 1, and
n rating for overall artifacts of Reviewers #1 and #2 was 2. Abbre-
n as in Figure 1.dentified in the SS-MRA, but not in the FP-
RA (Fig. 4).
tudy limitations. First, the study is limited by its
etrospective design (e.g., possible patient selec-
ion bias). Second, the weight-adjusted dosage of
adofosveset trisodium can lead to injection of
ow volumes of contrast media, and thus may
nfluence overall vessel delineation in the FP-
RA. However, in this retrospective analysis,
he comparison of 2 different contrast agents was
ot possible and would be considered unethical in
hildren. Third, 2 different MRA techniques are
ompared against each other without comparison
gainst a gold standard technique (catheter
ngiography).
onclusions
n summary, we demonstrated that a high-
esolution, cardiac- and respiratory-gated MRA
equence during the steady-state phase of gadofos-
eset trisodium delivers superior image quality and
mproves vessel delineation compared with a stan-
ard dynamic MRA sequence during the first pass
f the contrast agent. This improvement in image
uality and sharpness allowed for exclusive identi-
cation of clinically relevant anatomic structures in
he SS-MRA, which could not be detected in the
P-MRA.
A possible disadvantage of this imaging approach
s the lack of dynamic information that cannot be
erived from the high-resolution SS-MRA. There-
ore, the combination of a FP and SS imaging
rotocol using a blood-pool contrast agent is a
romising clinical approach for imaging of the
horacic vasculature, which warrants further inves-
igation in the future. The proposed approach for
maging of the thoracic vasculature may prove
pecifically useful in children with congenital heart
isease, where vessel conspicuity and delineation are
imited by spatial resolution and respiratory motion
rtifacts.
cknowledgment
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n this paper.
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